 [3] 
  Servier Canada obtained a NOC for perindopril erbumine in 2 and 4 mg tablets on September 21, 1994 and a NOC for perindopril erbumine in 8 mg tablets on October 16, 2002. The 2, 4 and 8 mg tablets of perindopril erbumine are distributed by Servier Canada under the trade-mark COVERSYL.